University of Alabama at Birmingham, Birmingham, AL, USA.
City of Hope, Duarte, CA, USA.
Leukemia. 2024 Jul;38(7):1592-1599. doi: 10.1038/s41375-024-02238-2. Epub 2024 Apr 5.
We examined the prevalence, risk factors, and association between pre-frailty and subsequent mortality after blood or marrow transplantation (BMT). Study participants were drawn from the BMT Survivor Study (BMTSS) and included 3346 individuals who underwent BMT between 1974 and 2014 at one of three transplant centers and survived ≥2 years post-BMT. Participants completed the BMTSS survey at a median of 9 years from BMT and were followed for subsequent mortality for a median of 5 years after survey completion. Closest-age and same-sex biological siblings also completed the survey. Previously published self-reported indices (exhaustion, weakness, low energy expenditure, slowness, unintentional weight loss) classified participants as non-frail (0-1 indices) or pre-frail (2 indices). National Death Index was used to determine vital status and cause of death. Overall, 626 (18.7%) BMT survivors were pre-frail. BMT survivors had a 3.2-fold higher odds of being pre-frail (95% CI = 1.9-5.3) compared to siblings. Compared to non-frail survivors, pre-frail survivors had higher hazards of all-cause mortality (adjusted hazard ratio [aHR] = 1.6, 95% CI = 1.4-2.0). Female sex, pre-BMT radiation, smoking, lack of exercise, anxiety, and severe/life-threatening chronic health conditions were associated with pre-frailty. The novel association between pre-frailty and subsequent mortality provides evidence for interventions as pre-frail individuals may transition back to their robust state.
我们研究了血液或骨髓移植(BMT)后衰弱前期的流行率、危险因素及其与随后死亡率之间的关系。研究参与者来自 BMT 幸存者研究(BMTSS),包括 1974 年至 2014 年间在三个移植中心之一接受 BMT 且在 BMT 后至少存活 2 年的 3346 名个体。参与者在 BMT 后中位数 9 年完成 BMTSS 调查,并在调查完成后中位数 5 年进行后续死亡率随访。年龄相近的同性生物学兄弟姐妹也完成了调查。以前发表的自我报告指数(疲劳、虚弱、低能量消耗、缓慢、非自愿性体重减轻)将参与者分为非虚弱(0-1 个指数)或衰弱前期(2 个指数)。国家死亡指数用于确定生存状态和死亡原因。总体而言,626 名(18.7%)BMT 幸存者处于衰弱前期。与兄弟姐妹相比,BMT 幸存者衰弱前期的可能性高出 3.2 倍(95%CI=1.9-5.3)。与非虚弱幸存者相比,衰弱前期幸存者的全因死亡率风险更高(调整后的危险比[aHR]=1.6,95%CI=1.4-2.0)。女性、BMT 前放疗、吸烟、缺乏运动、焦虑和严重/威胁生命的慢性健康状况与衰弱前期有关。衰弱前期与随后死亡率之间的新关联为干预提供了证据,因为衰弱前期个体可能会恢复到其强健状态。